2.Retrospective analysis of the relation between the clinical features and prognosis of 12 solitary plasmacytoma of bone patients
Wenjuan ZHANG ; Hongmei JING ; Xiaoyan KE ; Xin HUANG ; Zifen GAO
China Oncology 2006;0(12):-
Background and purpose:Solitary plasmacytoma of bone(SBP) is a rare disease,reports releveant to this disease are rarely seen. The purpose of this study was to investigate the relation between the clinical features and the prognosis of solitary plasmacytoma of bone. Methods:We reviewed the data of 12 patients diagnosed with solitary plasmacytoma of bone from 1998 to 2007 in Peking University third hospital,the clinical features,treatment and prognosis of the patients were analyzed retrospectively. Results:The age ranged from 37-71 years(mean 49.6 years) ,the male/female ratio was 3 to 1. Immunophenotype analysis showed that 11(91.6%) cases were positive for CD79a,10(83.3%) positive forVS38C,and all negative for CD20. With 12 to 87 months follow-up(average 40?22 months) ,three cases(33%) developed to multiple myeloma,two of them died from infection,the median survival time was 73 months,the 3 year and 5 year survival rate were 90 percent and 75 percent respectively. Conclusion:Middle and old male are more likely to develop SP. The prognosis is good,but some of them can progress to multiple myeloma.
3.The sensitivity of patient-specific VMAT QA to MLC positioning errors
Qingxin WANG ; Jianrong DAI ; Ke ZHANG ; Xin YANG
Chinese Journal of Radiological Medicine and Protection 2013;33(4):388-391
Objective To evaluate the sensitivity of patient-specific volumetric-modulated arc therapy (VMAT) quality assurance (QA) to minor multileaf collimator (M LC) positioning errors.Methods Systematic multileaf collimator (MLC) positioning errors (+0.5 mm,+ 1 mm and +2 mm) were introduced into the clinical VMAT patient plans with 2 types of MLC positioning errors:systematic MLC gap width errors and systematic MLC shift errors for 6 cases,including 3 cases with prostatic cancer and 3 cases with nasopharyngeal cancer.The planar dose distributions of the original and modified plans were measured using ArcCheck array.The coincidence between the measured results and the calculated results was evaluated using both absolute distance-to-agreement (AD-DTA) analysis with 3%/3 mm and 2%/2 mm criteria.Results The average passing rate of the 6 original VMAT plans was 96.0% with the ADDTA criteria of 3%/3 mm which was commonly adopted in clinical practice.For the MLC gap width errors of + 1 mm,+2 mm,and-2 mm and the MLC shift errors of 2 mm,the drop levels in average passing rate with the AD-DTA criteria of 3%/3 mm were 8.8%,15.5%,6.1% and 7.9%,respectively.The + 2 mm MLC positioning errors and + 1 mm MLC gap width errors could be detected by the patient-specific VMAT QA procedure.The AD-DTA criteria of 2%/2 mm was more sensitive compared with the criteria of 3%/3 mm.Conclusions Patient-specific VMAT QA is not sensitive enough to detect the systematic MLC positioning errors within 1 mm.Additional MLC QA is needed to guarantee the accuracy of VMAT delivery.
4.An Outbreak of Seasonal Influenza Viruses A(H1N1) in Changsha Was Diagnosed by Laboratory and the HA Gene Characteristic Was Analyzed
Ke-Yun SONG ; Ru-Sheng ZHANG ; Xin-Hua OU ;
Microbiology 2008;0(12):-
To determine the etiologic agent of an outbreak of influenza viruses from Changsha Foothill Mountain International School in 2009, and to analyze the HA Gene Characteristic of the H1N1 influenza viruses. Twenty-five nasopharyngeal swab specimens from the outbreak of influenza viruses were tested by conventional RT-PCR and influenza viruses isolated simultaneously. Virus isolated (A/Yuelu/314/2009) from the outbreak was sequenced by CEQTM 8000 Genetic Analysis System and the sequencing results submitted to GenBank (Accession No: FJ912843), then the sequencing data was analyzed by ClustalX and Mega4.1softwares. Results showed the influenza viruses A(H1N1) of positive were 18 cases by influenza viruses isolated tests and 21 cases by conventional RT-PCR, respectively. The nucleotide and amino acid sequence homology of the HA gene of A/Yuelu/314/2009 are 99% compare with the vaccine strain (A/Brisbane/59/2007) in 2008~2009 years. The HA sequence data also showed that had 6 amino acid mutations (V148A, S158N, G202A, I203D, A206T, W435R), and the S158N located at antigenic site B of HA protein. Nine potential glycosylation sites (27, 28, 40, 71, 151, 176, 303, 497, 536) in the HA sequence of A/Yuelu/314/2009 is the same with A/Brisbane/59/2007, and the sequences of potential glycosylation sites were conserved. In this study, laboratory evidence diagnosed seasonal influenza A virus (H1N1) as the etiologic agent of the outbreak. The virus isolated (A/Yuelu/314/2009) strain of H1N1 subtype is not a new variant in Changsha in 2009 compare with the vaccine strain (A/Brisbane/59/2007), the outbreak of influenza A virus (H1N1) from Changsha Foothill Mountain International School maybe are caused by the change in genetic characteristics between vaccine strains and the decreased of immunity to influenza A virus (H1N1) in the crowd.
6.Clinical Characteristics of Solid Cystic Papillary Tumor in Children
xiang-yu, HOU ; xin-yuan, LI ; xin, ZHOU ; ke-ren, ZHANG
Journal of Applied Clinical Pediatrics 2006;0(20):-
Objective To explore clinical characteristics of diagnosis and treatment of solid-cystic papillary tumor(SCPT) of the pancreas in children.Methods There were retrospectively analyzed about the 7 patients treated in our hospital for SCPT,with the ave-rage age of 11.5 years.All patients complained abdominal pain following a trauma(71.4%) or overeating(28.6%).The main presentation was abdominal mass.Of the 7 patients,4 received distal pancreatectomy,2 pancreatico-duodenectomy,and 1 only biopsy.Results The nicks of all patients were primany hed.All patients were pathologically confirmed as SCPT after operation.All patients were followed up for 4 monthes to 4.5 years,the recent result was well.Conclusions SCPT is a low-grade malignant tumor,which is often asymptomatic,but the patients with symptoms generally suffer from an abdominal mass or abdominal pain.The prognosis is excellent after operation.
7.Effect of growth hormone combined with Radix Dipsaci on the body growth and the bone metabolism of hypophysectomized rats.
Ying-ke LIU ; Zhi-xin ZHANG ; Qiong ZHANG
Chinese Journal of Integrated Traditional and Western Medicine 2011;31(12):1690-1694
OBJECTIVETo study the effect of growth hormone (GH) combined with Radix Dipsaci on the body growth and the bone mineral content (BMC) of hypophysectomized rats.
METHODSThe GH deficiency rats model was established using the hypophysectomized operation through the skull and the throat. Qualified rats were divided into the sham-operation group (n = 15), the negative control group (n = 13), the GH intervention group (n = 13), and the GH combined with Radix Dipsaci group(n = 12). GH (0.25 mg/kg) was subcutaneously injected from the cervical part in the GH intervention group and the GH combined with Radix Dipsaci group at the same time, while equal volume of normal saline was injected to the rest groups. 0.7 mL/100 kg Radix Dipsaci was given by gastrogavage to the GH combined with Radix Dipsaci group at the same time, while equal volume of normal saline was given by gastrogave to the rest groups. The body weight, the tail length, and the body length were measured during the intervention period. Blood was withdrawn after 14-day intervention. The femoral bone and the tibial bone were taken out. The levels of GH, insulin-like growth factor 1 (IGF-1), alkaline phosphatase (ALP), and osteocalcin (OC) were measured. The width of the tibial epiphyseal plate was measured. The bilateral femur bone mineral density (BMD) and BMC were measured using the dual energy X-ray absorptiometry.
RESULTSThe body weight, the body length, the length of the femoral bone, the length of the tibial bone, the width of the epiphyseal plate, the levels of the GH, IGF-1, ALP, and OC increased in the GH intervention group and the GH combined with Radix Dipsaci group after 2-week intervention, showing statistical difference when compared with the model group (P < 0.01). But there was no statistical difference in the tail length though it also increased (P > 0.05). There was insignificant difference in the aforesaid indices between the two groups (P > 0.05). Compared with the model group, the BMD of the GH combined with Radix Dipsaci group increased with statistical difference (P < 0.01). Compared with the model group, the BMC of the GH intervention group and the GH combined with Radix Dipsaci group increased with statistical difference (P < 0.01). It was highest in the GH combined with Radix Dipsaci group (P < 0.01).
CONCLUSIONSGH combined with Radix Dipsaci showed unobvious effect on promoting the growth. But it could elevate BMD and BMC, and improve the bone metabolism.
Animals ; Bone Development ; drug effects ; Bone and Bones ; metabolism ; Dipsacaceae ; chemistry ; Drugs, Chinese Herbal ; pharmacology ; Growth Hormone ; pharmacology ; Hypophysectomy ; Male ; Rats ; Rats, Sprague-Dawley
9.A comparative study of mechanical experiment and three-dimensional finite element analysis on fracture mode of all-ceramic molar crowns
Qin-Qin WANG ; Jun ZHANG ; Ke ZHAO ; Xin-Ping ZHANG
Chinese Journal of Stomatology 2008;43(11):680-683
Objective To investigate the influence of indenter diameter on fracture strength and fracture mode of IPS e. max all-ceramic crowns using mechanical experiments and three-dimensional finite element (3-DFE) method, to validate the 3-DFE model using mechanical experiments, and to provide a guideline for occlnsal surface design for IPS e. max all-ceramic crowns. Methods A 3-DFE model of an all-ceramic crown on a molar was established using ANSYS10.0 software. The 3-DFE crown was loaded occlusally at three points to simulate the contact points of a hemispherical indenter loading on the crown. Two indenter diameters (4 mm and 10 mm) were designed by changing loading point, load level and its direction. The stress distribution and the principal stress in the 3-DFE model were calculated. Meanwhile, IPS e. max ceramic crowns were made on a laboratory model and loaded with indenters. The diameters of the indenters were also 4 mm and 10 mm respectively. Fracture mode and fracture-resistance of the crowns were recorded. Results The principal stress increased as load increases for both small and large indenters. Stress concentrated in the central fossa of the 3-DFE crown when loaded with the small indenter. Stress concentration appeared in the middle area of the occlusal surface mesio-distally when 3-DFE crown was loaded with large indenter. The fracture-resistance load was 600 N to 700 N for 4 mm diameter indenter, and 2500 N to 2750 N for 10 mm diameter indenter. Mechanical experiments indicated the same results as those from 3-DFE analysis. Conclusions Both the three-dimensional finite element analysis and the mechanical experiment showed the same results. When loaded with 4 mm diameter indenter, fracture occured in the central fossa of the crown, however, 10 mm diameter indenter usually caused extensive crown damage.
10.Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
Ji YOU-XIN ; Zhang ZHONG-FA ; Lan KE-TAO ; Nie KE-KE ; Geng CHUAN-XIN ; Liu SHI-CHAO ; Zhang LING ; Zhuang XING-JUN ; Zou XIAO ; Sun LEI ; Zhang ZONG-CHUN
Chinese Medical Sciences Journal 2014;(1):7-14
Objective To explore the efficacy and safty of sorafenib in Child-Pugh class B to class C hepatocellular carcinoma (HCC).
Methods In this three-center open-label study from November 2011 to May 2013, we randomly assigned 189 patients with advanced Child-Pugh class B or C HCC patients into two groups, one group with 95 patient to receive sorafenib (400 mg a time, twice a day) and the other group with 94 patients to receive best supportive care. The primary end points were progression-free survival and overall survival.
Results The median progression-free survival was 2.2 months and 1.9 months in the sorafenib group and best supportive care group respectively (Hazard ratio in the sorafenib group, 0.55; 95% confidence interval, 0.40-0.75;P=0.002). The median overall survival was 4.0 months and 3.5 months in the sorafenib group and best supportive care group respectively (Hazard ratio in the sorafenib group, 0.48;95%confidence interval, 0.35-0.68;P<0.001). The main adverse effect of sorafenib was rash and acne of the skin (in 51.7%patients). The incidences of severe rash, diarrhea, and dry skin were 5.6%, 5.6%, and 2.2%in the sorafenib group. One patient reached partial response in the sorafenib group.
Conclusions Sorafenib is safe in patients with liver function impaired advanced HCC. It is effective in terms of progression-free survival and overall survival compared with best supportive care. Liver functions are the important predictive factors.